Photodynamic diagnostics in the urinary tract: Consensus paper of the Working Group for Oncology of the German Society for Urology;Photodynamische diagnostik im harntrakt: Konsensusempfehlungen des Arbeitskreises Onkologie der Deutschen Gesellschaft für Urologie

Urologe - Ausgabe A

Volumn 47, Issue 8, 2008, Pages 982-987

  Stenzl, A ^a   Jocham, D ^b   Jichlinski, P ^c   Junker, K ^d   Konig F ^e   Van Den Bergh, H ^f   Volkmer, B ^g   Zaak, D ^h   Gschwend, J E ⁱ  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d JENA UNIVERSITY HOSPITAL   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f Laboratory of Atmospheric Pollution and Climate Studies (LPAS)   (Switzerland)

^g UNIVERSITY HOSPITAL ULM   (Germany)

^h UNIVERSITY OF MUNICH   (Germany)

ⁱ TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Bladder cancer; Costs; Guidelines; Hexylaminolaevulinic acid; Photodynamic diagnosis (PDD)

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID HEXYL ESTER;

BLADDER CARCINOMA; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GROWTH; CANCER RECURRENCE; CARCINOMA IN SITU; CONSENSUS; DIAGNOSTIC PROCEDURE; DYSPLASIA; GERMANY; MEDICAL SOCIETY; PHOTODYNAMIC DIAGNOSIS; PHOTODYNAMICS; REVIEW; TRANSURETHRAL RESECTION; URINARY TRACT; UROGENITAL TRACT TUMOR; WORLD HEALTH ORGANIZATION;

AMINOLEVULINIC ACID; HUMANS; MEDICAL ONCOLOGY; MICROSCOPY, FLUORESCENCE; PHOTOSENSITIZING AGENTS; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL; UROLOGIC NEOPLASMS; UROLOGY;

EID: 49349114343     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-008-1791-5     Document Type: Review

References (28)

1. AUA Guidelines (1999) Non-muscle invasive bladder cancer. http://www.auanet.org/guidelines
2. Benson 1982 Mayo Clin Proc 57 548
3. Botteman 2003 Pharmacoeconomics 21 1315
4. Burger 2007 Eur Urol 52 142
5. Bush 1967 J Med Soc N J 64 56
6. EAU Guidelines (2006) TaT1 non-muscle invasive Bladder Cancer 2006. http://www.uroweb.org/professional-resources/guidelines
7. GLOBOCAN-Schätzung (2002) RKI-Schätzung für Deutschland 2002. http://www-dep.iarc.fr/globocan/downloads.htm
8. Grossman 2007 J Urol 178 62
9. Hall 2007 J Urol 178 2314
10. Hartmann 1999 Am J Pathol 154 721
11. Hedelin 2002 Scand J Urol Nephrol 36 344
12. Jichlinski 2003 SPIE 5141 272
13. Jocham 1989 Urologe A 28 59
14. Jocham 6 Eur Urol 53 1138
15. Junker 2002 Int J Oncol 20 647
16. Kennedy 1990 J Photochem Photobiol B 6 143
17. Kriegmair 1994 Urology 44 836
18. Lange 1999 Br J Cancer 80 185
19. Marti 1999 J Urol 162 546
20. Marti 2003 J Urol 170 428
21. Obermann 2003 J Pathol 199 50
22. Penkoff J, Steiner J, Dajc-Sommerer E et al. (2007) Transurethral detection and resection of bladder carcinomas under white or 5-ALA induced fluorescence light: results of the first double-blind-placebo controlled clinical trial. AUA 2007. Abstract 1085
23. Schmidbauer 2004 J Urol 171 135
24. SIGN (2005) Management of transitional cell carcinoma of the bladder. http://www.sign.ac.uk/pdf/sign85.pdf
25. Sobin L, Wittekind C (2002) TNM Classification of malignant tumors. 6th edn. Wiley-Liss, New York
26. Stenzl A (2008) Bladder cancer economics. SatelliteSymposium, EAU Annual Meeting 2008: How can we improve the management of non-invasive bladder cancer? Milan, March 26, 2008
27. Stenzl 2001 Eur Urol 39 31
28. Uehlinger 2000 J Photochem Photobiol B 54 72